Zobrazeno 1 - 10
of 11
pro vyhledávání: '"B Reques"'
Autor:
L Morales Martinez, C Saez Bertrand, B Reques, G. Sevilla Santos, M Blasco Guerrero, C Martín Blas
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Dose adjustment according to estimated glomerular filtration rate (eGFR) in patients with renal failure (RF) is important in avoiding adverse effects, and changes in the intensity and duration of the pharmacological effect. Purpose To asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfb23d6e76e0b9d793d9eaee78252faa
https://doi.org/10.1136/ejhpharm-2019-eahpconf.221
https://doi.org/10.1136/ejhpharm-2019-eahpconf.221
Publikováno v:
Clinical pharmacy.
Background Valproic acid (VPA) frequently causes severe intoxication which is difficult to recognise in critically ill patients (CIP). Hypoalbuminaemia is a common finding in CIP associated with changes in drug protein binding. VPA is extensively bou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65e608d2beac624d8c43a5be4de53f3e
https://doi.org/10.1136/ejhpharm-2017-000640.213
https://doi.org/10.1136/ejhpharm-2017-000640.213
Autor:
J Sánchez-Rubio Ferrández, L López Esteban, B Reques Sastre, C Martín Blas, A Onteniente González, T Molina García
Publikováno v:
European Journal of Hospital Pharmacy. 23:A82.3-A83
Background Knowledge of HIV+ patients about their disease and antiretroviral treatment (ART) has been associated with adherence and clinical outcomes. Purpose To determine the degree of knowledge about disease and treatment in HIV+ patients and to an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baf6edf2782c7ea07244151e46bdd534
https://doi.org/10.1136/ejhpharm-2016-000875.187
https://doi.org/10.1136/ejhpharm-2016-000875.187
Autor:
R Vazquez-Sanchez, J Sánchez-Rubio-Ferrandez, A Onteniente-González, A Liras-Medina, B Reques, ME Martinez-Nuñez, T Molina
Publikováno v:
European Journal of Hospital Pharmacy. 23:A191.3-A192
Background Initial intravenous dosing with vancomycin should be based on actual body weight (ABW) and subsequent dose titration based on renal function and serum trough concentrations. The manufacturer´s labelling recommends 500 mg/6 h or 1000 mg/12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::803f4e07bbc2c308c957a8249493b50d
https://doi.org/10.1136/ejhpharm-2016-000875.433
https://doi.org/10.1136/ejhpharm-2016-000875.433
Publikováno v:
European Journal of Hospital Pharmacy. 23:A137.3-A138
Background Pancreatic cancer is a disease with a poor prognosis, palliative treatment being the goal of treatment for most patients. Although chemotherapy needs to be tailored to the patient’s preference, treatment tolerance and disease characteris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1dd6f906d93886dc56d562583edfb384
https://doi.org/10.1136/ejhpharm-2016-000875.312
https://doi.org/10.1136/ejhpharm-2016-000875.312
Publikováno v:
European Journal of Hospital Pharmacy. 23:A36.2-A37
Background Biological based therapies, such as subcutaneous anti-tumour necrosis factor α, including etanercept or adalimumab, or ustekinumab, an agent which targets interleukin (IL)-12 and IL-13 cytokines, has greatly improved treatment of psoriasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bcec86d5bd8c987c0754e0cb2fc8fbc
https://doi.org/10.1136/ejhpharm-2016-000875.83
https://doi.org/10.1136/ejhpharm-2016-000875.83
Autor:
A Onteniente-González, B Reques Sastre, T Molina García, ME Martínez Nuñez, L López Esteban, R Vázquez Sánchez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A39.2-A39
Background Abiraterone is indicated for the treatment of metastatic castration-resistant prostate cancer. One of the most common side effects (affecting more than 10% of patients) associated with abiraterone is urinary tract infection (UTI). Purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b65de47ed2c43d72de8f317d31f40205
https://doi.org/10.1136/ejhpharm-2015-000639.94
https://doi.org/10.1136/ejhpharm-2015-000639.94
Autor:
L López Esteban, R Vázquez Sánchez, T Molina García, J Sánchez-Rubio Ferrández, B Reques Sastre, A Liras Medina
Publikováno v:
European Journal of Hospital Pharmacy. 22:A42.1-A42
Background Multiple sclerosis is a chronic inflammatory disorder of the central nervous system. Statins have demonstrated anti-inflammatory and immunomodulatory properties in this setting. Several clinical studies of different statins, given alone or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32fa91b08f90a470de73477f9fa90002
https://doi.org/10.1136/ejhpharm-2015-000639.100
https://doi.org/10.1136/ejhpharm-2015-000639.100
Autor:
J Sánchez-Rubio Ferrández, L López Esteban, R Vázquez Sánchez, ME Martínez Nuñez, T Molina García, B Reques Sastre
Publikováno v:
European Journal of Hospital Pharmacy. 22:A44.2-A44
Background Treatment of human immunodeficiency virus (HIV) infected patients usually involves the use of complex regimens and adverse effects. Current guidelines recommend treatment simplification in patients with effective infection control by switc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::192871a7feca075fd429519d87ae8c46
https://doi.org/10.1136/ejhpharm-2015-000639.105
https://doi.org/10.1136/ejhpharm-2015-000639.105
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.